Equity Plans and Stock-based Compensation (Tables)

6 Months Ended

Jul. 31, 2026

Share-Based Payment Arrangement [Abstract]

Schedule of Stock-Based Compensation Expense

The following sets forth the total stock-based compensation expense for employee equity plans included in the Company’s condensed consolidated statements of operations:


	Three Months Ended July 31,				Six Months Ended July 31,
	2026		2025		2026		2025
	(in thousands)
Cost of revenue	$	871	$	1,251	$	1,862	$	2,474
Research and development	5,027		9,174		10,460		17,788
Sales and marketing	1,770		2,876		3,652		5,955
General and administrative	3,297		4,915		5,587		9,862
Total stock-based compensation expense	$	10,965	$	18,216	$	21,561	$	36,079

Share-based Payment Arrangement, Restricted Stock and Restricted Stock Unit, Activity

A summary of RSUs outstanding under the 2021 EIP as of July 31, 2026 and changes during the fiscal year-to-date period then ended is presented in the following table, adjusted on a retroactive basis to reflect the Reverse Stock Split as discussed in Note 1, Description of Business and Basis of Presentation:


	Number of Shares	Weighted Average Grant Date Fair Value per Share
Outstanding as of January 31, 2026	2,195,297	$	26.56
RSU granted	1,393,147	$	7.46
RSU vested	(845,171)	$	28.62
RSU forfeited	(284,253)	$	24.55
Outstanding as of July 31, 2026	2,459,020	$	15.26

A summary of PRSUs outstanding under the 2021 EIP as of July 31, 2026 and changes during the fiscal year-to-date period then ended is presented in the following table, adjusted on a retroactive basis to reflect the Reverse Stock Split as discussed in Note 1, Description of Business and Basis of Presentation:


	Number of Shares	Weighted Average Grant Date Fair Value per Share
Outstanding as of January 31, 2026	444,933	$	23.22
PRSUs granted	—	$	—

PRSU forfeited	—	$	—
Outstanding as of July 31, 2026	444,933	$	23.22

Share-based Payment Arrangement, Option, Activity

A summary of stock options outstanding under the 2017 Plan and 2007 Plan as of July 31, 2026 and changes during the fiscal year-to-date period then ended is presented in the following table, adjusted on a retroactive basis to reflect the Reverse Stock Split as discussed in Note 1, Description of Business and Basis of Presentation:


	Number of Stock Option Awards	Weighted Average Exercise Price		Weighted Average Remaining Contractual term (in years)	Aggregate Intrinsic Value (in thousands)
Outstanding as of January 31, 2026	118,756	$	15.51	3.1	$	—

Options expired	(9,034)	$	14.31
Outstanding as of July 31, 2026	109,722	$	15.60	2.5	$	—
Options vested as of July 31, 2026	109,722	$	15.60	2.5	$	—
Exercisable as of July 31, 2026	109,722	$	15.60	2.5	$	—